Bosch sees car production falling 5% in 2019: report
July 27, 2019
Exact Sciences in advanced talks to buy Genomic Health for $2.8 billion: Bloomberg
July 27, 2019
0

Pfizer in talks to merge off-patent drugs business with Mylan -source

at
Categories
Tags
Pfizer Inc is in talks to merge its off-patent drugs business with Mylan NV in a stock deal, according to a source familiar with the matter.

Powered by WPeMatico

Muller&Green
Muller&Green

Related posts

June 18, 2020

Chanel warns virus impact will linger on luxury sector

Read more
June 18, 2020

IMF says deeper-than-expected contraction in U.S. economy likely in second quarter

Read more
June 18, 2020

Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million

Read more